<p>不幸的是，對於一些股東來説，<strong>MicroAlgo Inc.</strong>（納斯達克代碼：MLGO）的股價在過去三十天內下跌了 26%，延續了近期的痛苦。對於任何長期股東來説，上個月結束了一年值得遺忘的時光，鎖定了 96% 的股價下跌。</p>
<p>由於股價大幅下跌，MicroAlgo 目前可能發出買入信號，其市銷率（&#34;P/S&#34;）為 0.9 倍，考慮到美國 IT 行業幾乎一半的公司市銷率超過 2.2 倍，甚至市銷率高於 9 倍的情況也並不罕見。然而，市銷率低可能是有原因的，需要進一步調查以確定其合理性。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現的各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>查看我們對 MicroAlgo 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264"/></p>
<p>納斯達克 CM:MLGO 市銷率與行業比較 2025 年 12 月 30 日</p>
<h3>MicroAlgo 的市銷率對股東意味着什麼？</h3>
<p>例如，考慮到 MicroAlgo 最近的財務表現不佳，其收入一直在下降。一個可能性是，市銷率低是因為投資者認為該公司在不久的將來無法避免表現不及整體行業。看好 MicroAlgo 的人希望情況不是這樣，以便他們能夠以較低的估值買入該股票。</p>
<p>想要了解公司收益、收入和現金流的完整情況嗎？那麼我們對 MicroAlgo 的 <strong>免費</strong> 報告將幫助您揭示其歷史表現。</p>
<h2>MicroAlgo 是否有任何收入增長的預測？</h2>
<p>MicroAlgo 的市銷率對於一家預計僅能實現有限增長的公司來説是典型的，重要的是，其表現還將低於行業水平。</p>
<p>回顧一下，公司的收入增長去年並沒有讓人興奮，出現了令人失望的 28% 的下降。因此，三年前的收入總體也下降了 34%。所以不幸的是，我們必須承認該公司在這段時間內未能有效增長收入。</p>
<p>與行業相比，行業預計在未來 12 個月內將實現 19% 的增長，而該公司的近期中期收入結果所顯示的下行趨勢則是一個令人警醒的事實。</p>
<p>有了這些信息，我們並不感到驚訝 MicroAlgo 的市銷率低於行業水平。儘管如此，考慮到收入在下降，市銷率是否已經觸底並沒有保證。即使只是維持這些價格也可能很困難，因為近期的收入趨勢已經對股價造成了壓力。</p>
<h2>關鍵要點</h2>
<p>MicroAlgo 的市銷率隨着股價的下跌而下降。一般來説，我們傾向於將市銷率的使用限制在確定市場對公司整體健康狀況的看法上。</p>
<p>毫無疑問，MicroAlgo 在中期收入下滑的背景下維持其低市銷率。在這個階段，投資者認為收入改善的潛力不足以證明更高的市銷率是合理的。考慮到當前的情況，如果近期中期收入趨勢持續，股價在短期內出現顯著波動的可能性似乎不大。</p>
<p>此外，您還應該瞭解我們發現的 <strong>MicroAlgo 的 3 個警告信號</strong>（其中 1 個不容忽視）。</p>
<p>如果您對 MicroAlgo 的業務實力 <strong>不確定</strong>，為什麼不探索我們互動式的股票列表，尋找一些您可能錯過的基本面良好的公司呢？</p>
<p>用於國防和災難的移動基礎設施</p>
<p>下一波機器人技術不是類人型的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達，隨時隨地。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>由 CiTech 贊助</p>

MLGO

<p>MicroAlgo Inc.（納斯達克代碼：MLGO）在過去一個月的股價下跌了 26%，年內累計下降了 96%。該公司的市銷率（P/S）為 0.9 倍，遠低於 IT 行業平均水平的 2.2 倍，顯示出潛在的買入信號。然而，MicroAlgo 去年的收入下降了 28%，三年來下降了 34%，這引發了對其增長前景的擔憂。投資者保持謹慎，因為低市銷率反映了對未來收入改善的懷疑，暗示如果趨勢持續，股價的波動空間有限</p>

<p>Unfortunately for some shareholders, the <strong>MicroAlgo Inc.</strong> (NASDAQ:MLGO) share price has dived 26% in the last thirty days, prolonging recent pain. For any long-term shareholders, the last month ends a year to forget by locking in a 96% share price decline.</p>
<div class="lb-trans"><p>不幸的是，對於一些股東來説，<strong>MicroAlgo Inc.</strong>（納斯達克代碼：MLGO）的股價在過去三十天內下跌了 26%，延續了近期的痛苦。對於任何長期股東來説，上個月結束了一年值得遺忘的時光，鎖定了 96% 的股價下跌。</p>
</div><p>Since its price has dipped substantially, MicroAlgo may be sending buy signals at present with its price-to-sales (or &#34;P/S&#34;) ratio of 0.9x, considering almost half of all companies in the IT industry in the United States have P/S ratios greater than 2.2x and even P/S higher than 9x aren't out of the ordinary. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>由於股價大幅下跌，MicroAlgo 目前可能發出買入信號，其市銷率（&#34;P/S&#34;）為 0.9 倍，考慮到美國 IT 行業幾乎一半的公司市銷率超過 2.2 倍，甚至市銷率高於 9 倍的情況也並不罕見。然而，市銷率低可能是有原因的，需要進一步調查以確定其合理性。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現的各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>View our latest analysis for MicroAlgo</p>
<div class="lb-trans"><p>查看我們對 MicroAlgo 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264" alt="" original-src="https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264"/></p>
<p>NasdaqCM:MLGO Price to Sales Ratio vs Industry December 30th 2025</p>
<div class="lb-trans"><p>納斯達克 CM:MLGO 市銷率與行業比較 2025 年 12 月 30 日</p>
</div><h3>What Does MicroAlgo's P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>MicroAlgo 的市銷率對股東意味着什麼？</h3>
</div><p>For example, consider that MicroAlgo's financial performance has been poor lately as its revenue has been in decline. One possibility is that the P/S is low because investors think the company won't do enough to avoid underperforming the broader industry in the near future. Those who are bullish on MicroAlgo will be hoping that this isn't the case so that they can pick up the stock at a lower valuation.</p>
<div class="lb-trans"><p>例如，考慮到 MicroAlgo 最近的財務表現不佳，其收入一直在下降。一個可能性是，市銷率低是因為投資者認為該公司在不久的將來無法避免表現不及整體行業。看好 MicroAlgo 的人希望情況不是這樣，以便他們能夠以較低的估值買入該股票。</p>
</div><p>Want the full picture on earnings, revenue and cash flow for the company? Then our <strong>free</strong> report on MicroAlgo will help you shine a light on its historical performance.</p>
<div class="lb-trans"><p>想要了解公司收益、收入和現金流的完整情況嗎？那麼我們對 MicroAlgo 的 <strong>免費</strong> 報告將幫助您揭示其歷史表現。</p>
</div><h2>Is There Any Revenue Growth Forecasted For MicroAlgo?</h2>
<div class="lb-trans"><h2>MicroAlgo 是否有任何收入增長的預測？</h2>
</div><p>MicroAlgo's P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.</p>
<div class="lb-trans"><p>MicroAlgo 的市銷率對於一家預計僅能實現有限增長的公司來説是典型的，重要的是，其表現還將低於行業水平。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 28%. As a result, revenue from three years ago have also fallen 34% overall. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.</p>
<div class="lb-trans"><p>回顧一下，公司的收入增長去年並沒有讓人興奮，出現了令人失望的 28% 的下降。因此，三年前的收入總體也下降了 34%。所以不幸的是，我們必須承認該公司在這段時間內未能有效增長收入。</p>
</div><p>Comparing that to the industry, which is predicted to deliver 19% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.</p>
<div class="lb-trans"><p>與行業相比，行業預計在未來 12 個月內將實現 19% 的增長，而該公司的近期中期收入結果所顯示的下行趨勢則是一個令人警醒的事實。</p>
</div><p>With this information, we are not surprised that MicroAlgo is trading at a P/S lower than the industry. Nonetheless, there's no guarantee the P/S has reached a floor yet with revenue going in reverse. Even just maintaining these prices could be difficult to achieve as recent revenue trends are already weighing down the shares.</p>
<div class="lb-trans"><p>有了這些信息，我們並不感到驚訝 MicroAlgo 的市銷率低於行業水平。儘管如此，考慮到收入在下降，市銷率是否已經觸底並沒有保證。即使只是維持這些價格也可能很困難，因為近期的收入趨勢已經對股價造成了壓力。</p>
</div><h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><p>MicroAlgo's P/S has taken a dip along with its share price. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>MicroAlgo 的市銷率隨着股價的下跌而下降。一般來説，我們傾向於將市銷率的使用限制在確定市場對公司整體健康狀況的看法上。</p>
</div><p>It's no surprise that MicroAlgo maintains its low P/S off the back of its sliding revenue over the medium-term. At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio. Given the current circumstances, it seems unlikely that the share price will experience any significant movement in either direction in the near future if recent medium-term revenue trends persist.</p>
<div class="lb-trans"><p>毫無疑問，MicroAlgo 在中期收入下滑的背景下維持其低市銷率。在這個階段，投資者認為收入改善的潛力不足以證明更高的市銷率是合理的。考慮到當前的情況，如果近期中期收入趨勢持續，股價在短期內出現顯著波動的可能性似乎不大。</p>
</div><p>Plus, you should also learn about these <strong>3 warning signs we've spotted with MicroAlgo</strong> (including 1 which shouldn't be ignored).</p>
<div class="lb-trans"><p>此外，您還應該瞭解我們發現的 <strong>MicroAlgo 的 3 個警告信號</strong>（其中 1 個不容忽視）。</p>
</div><p>If you're <strong>unsure about the strength of MicroAlgo's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您對 MicroAlgo 的業務實力 <strong>不確定</strong>，為什麼不探索我們互動式的股票列表，尋找一些您可能錯過的基本面良好的公司呢？</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>用於國防和災難的移動基礎設施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是類人型的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達，隨時隨地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 贊助</p>
</div>

MicroAlgo Inc.（納斯達克股票代碼：MLGO）在股價下跌 26% 後顯得便宜，但可能還不足以吸引投資者